This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1946 Oct 19:132:362-8.

doi: 10.1001/jama.1946.02870420002002.

Experimental human bacillary dysentery; polyvalent dysentery vaccine in its prevention

H J SHAUGHNESSY, R C OLSSON, et al.

PMID: 20998311
DOI: 10.1001/jama.1946.02870420002002

Experimental human bacillary dysentery; polyvalent dysentery vaccine in its prevention

H J SHAUGHNESSY et al. J Am Med Assoc. 1946.

. 1946 Oct 19:132:362-8.

doi: 10.1001/jama.1946.02870420002002.

Authors

H J SHAUGHNESSY, R C OLSSON, et al.

PMID: 20998311
DOI: 10.1001/jama.1946.02870420002002

No abstract available

PubMed Disclaimer

Similar articles

[Result of the treatment of chronic bacillary dysentery with Besredka's vaccine].
ZIL'BERMAN BN. ZIL'BERMAN BN. Klin Med (Mosk). 1951 Jun;29(6):85-6. Klin Med (Mosk). 1951. PMID: 14851610 Undetermined Language. No abstract available.
Simultaneous vaccination against bacillary dysentery and cholera with toxoid-vaccine.
FELSENFELD O, YOUNG VM. FELSENFELD O, et al. Am J Trop Med Hyg. 1945;25:421. doi: 10.4269/ajtmh.1945.s1-25.421. Am J Trop Med Hyg. 1945. PMID: 21005340 No abstract available.
[Up to date experiences in the production of an anti-dysentery vaccine. (Preliminary communication)].
MEL D. MEL D. Vojnosanit Pregl. 1962 May;19:353-6. Vojnosanit Pregl. 1962. PMID: 13934625 Serbian. No abstract available.
Strategies for development of potential candidate Shigella vaccines.
Lindberg AA, Pál T. Lindberg AA, et al. Vaccine. 1993;11(2):168-79. doi: 10.1016/0264-410x(93)90014-o. Vaccine. 1993. PMID: 8438615 Review.
On Dysentery, Its Forms and Consequences.
[No authors listed] [No authors listed] Med Chir Rev. 1835 Apr 1;22(44):425-429. Med Chir Rev. 1835. PMID: 29918087 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.
Herrera CM, Schmitt JS, Chowdhry EI, Riddle MS. Herrera CM, et al. Vaccines (Basel). 2022 Apr 20;10(5):645. doi: 10.3390/vaccines10050645. Vaccines (Basel). 2022. PMID: 35632401 Free PMC article. Review.
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.
Porter CK, Lynen A, Riddle MS, Talaat K, Sack D, Gutiérrez RL, McKenzie R, DeNearing B, Feijoo B, Kaminski RW, Taylor DN, Kirkpatrick BD, Bourgeois AL. Porter CK, et al. PLoS One. 2018 Mar 28;13(3):e0194325. doi: 10.1371/journal.pone.0194325. eCollection 2018. PLoS One. 2018. PMID: 29590182 Free PMC article.
The Shigella human challenge model.
Porter CK, Thura N, Ranallo RT, Riddle MS. Porter CK, et al. Epidemiol Infect. 2013 Feb;141(2):223-32. doi: 10.1017/S0950268812001677. Epub 2012 Aug 21. Epidemiol Infect. 2013. PMID: 22906296 Free PMC article.
Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions.
Scott TA, Baker KS, Trotter C, Jenkins C, Mostowy S, Hawkey J, Schmidt H, Holt KE, Thomson NR, Baker S. Scott TA, et al. Nat Rev Microbiol. 2025 May;23(5):303-317. doi: 10.1038/s41579-024-01126-x. Epub 2024 Nov 27. Nat Rev Microbiol. 2025. PMID: 39604656 Review.
Shigella-Controlled Human Infection Models: Current and Future Perspectives.
Clarkson KA, Porter CK, Talaat KR, Kapulu MC, Chen WH, Frenck RW Jr, Bourgeois AL, Kaminski RW, Martin LB. Clarkson KA, et al. Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248. Curr Top Microbiol Immunol. 2024. PMID: 35616717 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions